Robert Schueren

Robert Schueren is the current COO at Natera. Robert has also previously served as the Independent Director at PerceptiMed, Inc., President, Chief Executive Officer at IntegenX. Inc., and Vice President/General Manager of the Genomics Solutions Division at Agilent Technologies.

Schueren has been instrumental in the success of each of these companies. At Agilent Technologies, they successfully led the company to generate over $100 million in operating profit over three years. Robert also played a key role in the development and launch of new product lines, including HaloPlex and SureSelect next gen sequencing kits, PCR and qPCR instruments, informatics, next gen microarrays and SureFISH.

At IntegenX, they were responsible for all channel aspects for genomics diagnostic products and genomics life science products. Robert also successfully completed the FDA registration of Cedar Creek, TX manufacturing site and CE marking of microarray system.

Schueren is a highly motivated individual with a proven track record of success in various leadership roles. Robert is a frequent presenter and contributor at Agilent Board and executive staff meetings, as well as analyst interface.

Robert Schueren graduated from Temple University School of Pharmacy with a Doctor of Pharmacy degree. Robert also holds a Bachelor of Science in Pharmacy from the same school. After working as a pharmacist for a few years, they decided to pursue a career in American Course Drug and Regulatory Sciences. Robert is currently enrolled in the University of California, San Francisco's program for this field.

Robert Schueren works with J. Dianne Keen - Kim - CLIA Laboratory Director, Bernie Tobin - General Manager, Organ Health, and Anu Pai - Head of R&D Program Management. Their manager is Steve Chapman, CEO.